Viewing Study NCT02691494


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2026-01-06 @ 9:18 PM
Study NCT ID: NCT02691494
Status: COMPLETED
Last Update Posted: 2021-07-13
First Post: 2016-02-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)
Sponsor: AbbVie
Organization: